Burchenal, J.H., Ellison, R.R. and Murphy, M.L. et al. (1954). Clinical studies on 6-mercaptopurine. Ann. N.Y. Acad. Sci. 60:359-368.
2.
Elion, G.B., Singer, S. and Hitchings, G.H. (1954). Microbiological effects of 6-mercaptopurine. Ann. N.Y. Acad. Sci. 60:200-206.
3.
Elion, G.B., Callahan, S., Rundles, R.W. and Hitchings, G.H. (1963). Relationship between metabolic fates and antitumor activities of thiopurines. Cancer Res. 23:1207-1217.
4.
Elion, G.B. (1967). The biochemistry and pharmacology of purine analogs . Fed. Proc. 26:898-904.
5.
Elion, G.B. (1975). Interaction of anticancer drugs with enzymes. In: Pharmacological Basis of Cancer Chemotherapy, M.D. Anderson Hospital and Tumor Institute, pp. 547-564. Baltimore: Williams and Wilkins Co.
6.
Elion, G.B. (1985). Selectivity-Key to Chemotherapy: Presidential Address. Cancer Res. 45:2943-2950.
7.
Hitchings, G.H., Elion, G.B., Falco, E.A., Russell, P.B. and Vander Werff, H. (1950). Studies on analogs of purines and pyrimidines. Ann. N.Y. Acad. Sci. 52:1318-1355.
8.
Hitchings, G.H. and Elion, G.B. (1972a). Mechanism of action of purine and pyrimidine analogues. In: Cancer Chemotherapy II, The Twenty-Second Hahnemann Symposium (ed. I. Brodsky, S.B. Kahn and J.H. Moyer), pp. 23-32. New York: Grune and Stratton.
9.
Hitchings, G.H. and Elion, G.B. (1972b). Specificities of purine metabolizing enzymes and implications for chemotherapy. In: The Purines-Theory and Experiment. The Jerusalem Symposia on Quantum Chemistry and Biochemistry IV , pp. 565-578. Jerusalem: Israel Academy of Sciences and Humanities .
10.
Hitchings, G.H. and Elion, G.B. (1985). Layer on Layer: The Bruce F. Cain Memorial Lecture . Cancer Res. 45:2415-2420.
11.
Philips, F.S., Sternberg, S.S., Hamilton, L. and Clarke, D.A. (1954). The toxic effects of 6-mercaptopurine and related compounds. Ann. N.Y. Acad. Sci. 60:283-296.
12.
Zimmerman, T.P., Chu, L.-C., Bugge, C.J.L., Nelson, D.J., Lyon, G.M. and Elion, G.B. (1974). Identification of 6-methylmercaptoribonucleoside 5'-diphosphate and 5'-triphosphate as metabolites of 6-mercaptopurine in man . Cancer Res. 34:221- 224.